Luis Diaz Jr., MD, was one of the researchers who led a 2022 clinical trial of a specific type of rectal cancer with a 100 percent success rate, Fast Company reported July 6.
Read the full post on Becker's Hospital Review - Healthcare News
1 oncologist's fight to stop cancer with a single drug
